Question 1

Who are the top researchers at Symphogen (Denmark)?

Accepted Answer

Ranked on the quality score, Ivan David Horak, Mikkel Wandahl Pedersen and John Sørensen Haurum lead among researchers whose main affiliation is Symphogen (Denmark).

Question 2

What are the most cited papers from Symphogen (Denmark)?

Accepted Answer

The most cited paper from Symphogen (Denmark) is "Novel antibody–antibiotic conjugate eliminates intracellular S. aureus" (Sophie M. Lehar et al., 2015), with 851 citations. Next come "The genomic landscape of response to EGFR blockade in colorectal cancer" (500) and "Targeting the ERBB family in cancer: couples therapy" (470).

Question 3

Which research topics does Symphogen (Denmark) publish most on?

Accepted Answer

By volume in 2022-now: Protein purification and stability, Advanced Proteomics Techniques and Applications, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.

Question 4

Which keywords describe research at Symphogen (Denmark)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Breast Cancer.

Question 5

Which fields of science does Symphogen (Denmark) work in?

Accepted Answer

In all years, 57% of research at Symphogen (Denmark) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (8%). It does 2.3× the world's share of Life Sciences.

Question 6

Is Symphogen (Denmark)'s research output growing?

Accepted Answer

Output in 2022-2025 was 72% lower than in 2018-2021.

Discussion